Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies.
about
The clinics of acute coronary syndromeThe role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioningCircadian influences on myocardial infarctionCysteine S-Nitrosylation Protects Protein-tyrosine Phosphatase 1B against Oxidation-induced Permanent InactivationRole of tetrahydrobiopterin in resistance to myocardial ischemia in Brown Norway and Dahl S rats.Protein S-nitrosylation and cardioprotectioneNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex.Cardioprotective PKG-independent NO signaling at reperfusionThe role of mitochondria in protection of the heart by preconditioning.Enhancement of nitric oxide release from nitrosyl hemoglobin and nitrosyl myoglobin by red/near infrared radiation: potential role in cardioprotectionA2B adenosine receptors inhibit superoxide production from mitochondrial complex I in rabbit cardiomyocytes via a mechanism sensitive to Pertussis toxinEffect of arginase inhibition on ischemia-reperfusion injury in patients with coronary artery disease with and without diabetes mellitus.Redox signalling and cardioprotection: translatability and mechanismDisruption of caveolae blocks ischemic preconditioning-mediated S-nitrosylation of mitochondrial proteins.Ischemic Preconditioning Mediates Neuroprotection against Ischemia in Mouse Hippocampal CA1 Neurons by Inducing Autophagy.Liposomal tetrahydrobiopterin preserves eNOS coupling in the post-ischemic heart conferring in vivo cardioprotection.The alpha1 isoform of soluble guanylate cyclase regulates cardiac contractility but is not required for ischemic preconditioningCyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling.Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer.Cardioprotection and mitochondrial S-nitrosation: effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia-reperfusion injuryTransfused older stored red blood cells improve the clinical course and outcome in a canine lethal hemorrhage and reperfusion modelMitochondria as a drug target in ischemic heart disease and cardiomyopathyEssential role of nitric oxide in acute ischemic preconditioning: S-nitros(yl)ation versus sGC/cGMP/PKG signaling?CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats.The paradigm of postconditioning to protect the heart.Mitochondrial nitroalkene formation and mild uncoupling in ischaemic preconditioning: implications for cardioprotection.In vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycineRole of glycogen synthase kinase-3beta in cardioprotection.Role of heat shock protein 90 and endothelial nitric oxide synthase during early anesthetic and ischemic preconditioning.Cardioprotection via preserved mitochondrial structure and function in the mPer2-mutant mouse myocardiumHyperlipidaemia induced by a high-cholesterol diet leads to the deterioration of guanosine-3',5'-cyclic monophosphate/protein kinase G-dependent cardioprotection in ratsROS and RNS signaling in heart disorders: could antioxidant treatment be successful?Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury.Protein S-nitrosylation in preconditioning and postconditioning.Signalling pathways and mechanisms of protection in pre- and postconditioning: historical perspective and lessons for the future.Vagal nerve stimulation reduces infarct size via a mechanism involving the alpha-7 nicotinic acetylcholine receptor and downregulation of cardiac and vascular arginase.Endothelial progenitor cells: Exploring the pleiotropic effects of statinsExogenous nitric oxide requires an endothelial glycocalyx to prevent postischemic coronary vascular leak in guinea pig hearts.Nitric oxide fails to confer endogenous antiarrhythmic cardioprotection in the primate heart in vitro.Reactive oxygen species production in energized cardiac mitochondria during hypoxia/reoxygenation: modulation by nitric oxide.
P2860
Q26746739-A64E6669-56CB-4D89-A7D9-2B374A5CEFEBQ26825733-8129A50F-CAD8-4D4A-AB2F-0185E0D673F9Q27008917-9E60C807-F024-4128-AE6F-5EDABB342CF6Q27652444-D63B4F79-BC5B-489A-8B17-6FA0062601D9Q29346977-473C7D58-658B-434E-B869-E984B6D703B2Q30385401-B3804C88-1BC3-4FA5-9AD2-3CDD80D8CBFCQ34092872-F6D198AA-D673-43E7-9E2C-221F0EEDE0BBQ34426209-EE055EB3-8C22-43E0-98AD-937EDE9457FBQ34581118-BB035EBB-3ABE-4881-8C3D-7A5B642A03F5Q35085904-0EF5CA6F-61A3-4530-9704-F722552FBA69Q35089870-1E1E84DE-5808-4AAD-95BF-665C2A5593EDQ35215102-B231F2C9-39AB-4B85-92BE-914F2393061DQ35286322-787364F9-EB8A-47F6-A51B-0F39D467E59AQ35556440-05113F08-AB7D-4993-A0C6-120B2523A026Q35760830-3D9CE5F9-BA60-486A-B971-4B2E2C2A4CE8Q36021710-B7D038D6-A5F9-4C57-824A-891F79BDB2CAQ36031657-118A7016-3158-4F1F-9981-6575BC1590F0Q36144664-4D9C0699-5D61-4AEB-8795-D28FA63C4CEDQ36229684-D5ED2C98-D557-4CF9-8366-E75AB3A9095DQ36259597-8B1A37ED-18D6-4BE3-B61F-E2BC6D3A4AE7Q36277833-ED18A5F2-BC6B-45A8-BDAF-3EF845CF295CQ36426316-2B4C83F9-1D49-4A45-8D38-B44F19D4F3D4Q36515988-56663AFC-F983-4803-BBFD-411AF28686A8Q36842525-7115A234-98B1-4A43-94AC-7F24FAA13C73Q37053179-3637C527-40C6-44B7-853B-0F40E2483036Q37176170-4A66DD6F-3F9B-450D-8078-56D57973D1B0Q37195014-49FA0600-B507-47CD-9064-8B2335AD39BBQ37303154-3006B4C7-2C77-4F83-B2EE-92282A126954Q37313904-25BC641B-6128-41F7-83D4-70DADDD4E968Q37476553-DB76FCC8-97A4-4726-84BD-9B2A96AA0267Q37481201-A2ACBE30-367B-48DF-BB0F-96A41406FEEDQ37931014-B6AC7834-A3B7-461D-A914-A8E6255B2C44Q38137849-A2E2DA93-CC8A-4042-B264-4898A6F7771CQ38199441-94BDFE9C-3ACC-4EF4-B941-24EC2FDFED01Q38247701-082197E5-D577-49F6-AF1C-5AF30EEB52ADQ38941643-4C4097FD-2268-46E8-AEBC-76B1B666C57BQ39121106-B1A7536D-A499-4E21-9923-1F3582A7CA84Q40823884-DA89BF21-49FB-42C1-85FD-930D7A729A5AQ41584845-09B45ED0-1913-42BF-81F9-E1DA8E34032DQ42276187-06F70D17-F209-45B0-89DB-EDEE94BD698C
P2860
Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Nitric oxide is a precondition ...... le infarct-sparing strategies.
@ast
Nitric oxide is a precondition ...... le infarct-sparing strategies.
@en
type
label
Nitric oxide is a precondition ...... le infarct-sparing strategies.
@ast
Nitric oxide is a precondition ...... le infarct-sparing strategies.
@en
prefLabel
Nitric oxide is a precondition ...... le infarct-sparing strategies.
@ast
Nitric oxide is a precondition ...... le infarct-sparing strategies.
@en
P2093
P1476
Nitric oxide is a precondition ...... le infarct-sparing strategies.
@en
P2093
James M Downey
Michael V Cohen
Xi-Ming Yang
P304
P356
10.1016/J.CARDIORES.2005.10.021
P577
2005-12-27T00:00:00Z